Elicio Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Elicio Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q2 2024.
  • Elicio Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 11.3M shares, a 290% increase year-over-year.
  • Elicio Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 5.06M shares, a 1500% increase from 2022.
  • Elicio Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 316K shares, a 98.9% decline from 2021.
  • Elicio Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 28.2M shares, a 91.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 11.3M +8.39M +290% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 10.3M +9.95M +3070% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 5.06M +4.74M +1500% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 8.38M +8.06M +2538% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.89M +2.58M +820% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 324K -29.6M -98.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 316K -27.9M -98.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 318K -29.5M -98.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 315K -29.4M -98.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 30M +6.52M +27.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 28.2M +13.5M +91.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 29.8M +15M +101% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 29.7M +15.2M +104% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 23.4M +8.98M +62.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 14.8M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 14.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 14.5M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 14.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.